The utility of the chimeric homeostatic cytokine, IL-7/IL-7Rα-Fc, partly restored APC activities in lung cancer, with a stronger capacity to process and present antigens to activate CD8+ T cells [64]. The gene discussed is IL7; the disease is lung carcinoma.